Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Sep 17:11:544186.
doi: 10.3389/fimmu.2020.544186. eCollection 2020.

Costimulation Blockade in Vascularized Composite Allotransplantation

Dimitrios Giannis  1 , Dimitrios Moris  2 , Linda C Cendales  2
Affiliations
Review

Costimulation Blockade in Vascularized Composite Allotransplantation

Dimitrios Giannis et al. Front Immunol. .

Abstract

Vascular composite allotransplantation (VCA) is a field under research and has emerged as an alternative option for the repair of severe disfiguring defects that result from infections or traumatic amputation in a selected group of patients. VCA is performed in centers with appropriate expertise, experience and adequate resources to effectively manage the complexity and complications of this treatment. Lifelong immunosuppressive therapy, immunosuppression associated complications, and the effects of the host immune response in the graft are major concerns in VCA. VCA is considered a quality of life transplant and the risk-benefit ratio is dissimilar to life saving transplants. Belatacept seems a promising drug that prolongs patient and graft survival in kidney transplantation and it could also be an alternative approach to VCA immunosuppression. In this review, we are summarizing current literature about the role of costimulation blockade, with a focus on belatacept in VCA.

Keywords: VCA; belatacept; costimulation blockade; hand transplantation; vascularized composite allotransplantation.

PubMed Disclaimer

References

    1. Gorantla VS, Plock JA, Davis MR. Reconstructive transplantation: evolution, experience, ethics, and emerging concepts. In: Subramaniam K, Sakai T. editors. Anesthesia and Perioperative Care for Organ Transplantation. New York, NY: Springer; (2017) p. 539–52.
    1. Diaz-Siso JR, Fischer S, Sisk GC, Bueno E, Kueckelhaus M, Talbot S, et al. Initial experience of dual maintenance immunosuppression with steroid withdrawal in vascular composite tissue allotransplantation: steroid withdrawal in VCA. Am J Transplant. (2015) 15:1421–31. 10.1111/ajt.13103 - DOI - PubMed
    1. Murphy BD, Zuker RM, Borschel GH. Vascularized composite allotransplantation: an update on medical and surgical progress and remaining challenges. J Plast Reconstr Aesthetic Surg. (2013) 66:1449–55. 10.1016/j.bjps.2013.06.037 - DOI - PubMed
    1. Vernon R, Wang J, Song M, Wilson N, Moris D, Cendales L. Vascularized composite allotransplantation: a functional hind limb model in mice. J Surg Res. (2020) 250:119–24. 10.1016/j.jss.2019.12.042 - DOI - PubMed
    1. Cherikh WS, Cendales LC, Wholley CL, Wainright J, Gorantla VS, Klassen DK, et al. Vascularized composite allotransplantation in the United States: a descriptive analysis of the organ procurement and transplantation network data. Am J Transplant. (2019) 19:865–75. 10.1111/ajt.15062 - DOI - PubMed

MeSH terms

LinkOut - more resources